We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radiation/Chemotherapy Combination Ups Glioma Survival Rates

By HospiMedica International staff writers
Posted on 19 Apr 2016
Patients with a low-grade glioma who received radiation therapy (RT) plus chemotherapy experienced a longer progression-free survival and overall survival than patients who received RT alone, according to a new study.

Researchers at the Mayo Clinic, Emory University and other institutions conducted a study involving 251 patients with grade 2 astrocytoma, oligoastrocytoma, or oligodendroglioma who were younger than 40 and had undergone subtotal resection or biopsy, or who were 40 years or older and had undergone biopsy or resection of any of the tumor. More...
The patients were randomly assigned to RT alone or to radiation therapy followed by six cycles of a combination chemotherapy that included procarbazine, lomustine, and vincristine (PCV).

The results showed that at a median follow-up time of 11.9 years, 67% of all enrolled patients were identified as having tumor progression, and 55% of the patients had died. Patients in the RT plus PCV chemotherapy arm had longer median survival times, compared with those who received RT alone (13.3 versus 7.8 years, respectively). Median progression- free survival time for patients receiving RT plus PCV chemotherapy was longer as well (10.4 years), compared to RT alone (four years).

In addition, 10-year progression-free survival rates for patients in the RT plus PCV chemotherapy arm were 51%, compared to 21% percent in the RT alone arm. For both progression-free survival and overall survival distributions, a difference between treatment arms became apparent only after two to four years following randomization. The favorable prognostic variables identified for survival included being in the radiation plus PCV chemotherapy arm and oligodendroglioma histology. The study was published on April 7, 2016, in the New England Journal of Medicine (NEJM).

“Our results indicate that initial radiation therapy followed by PCV is necessary to achieve longer survival in patients with grade 2 glioma, and that salvage therapy at relapse after radiation therapy alone is less effective,” said lead author oncologist Jan Buckner, MD, chair of the department of oncology at the Mayo Clinic Cancer Center. “Radiation therapy plus PCV appears to represent the most effective treatment identified to date for the majority of patients with grade 2 glioma.”

Grade 2 gliomas are relatively uncommon, constituting 5%–10% of all primary brain tumors in adults. They occur most commonly in young adults, and cause progressive neurologic deterioration and premature death.

Related Links:

Mayo Clinic
Emory University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Wound Irrigation Solution
Prontosan®
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.